Researchers developing potential coronavirus antibody therapies

Vanderbilt University Medical Center is teaming up with academic, governmental and corporate partners in an unprecedented, fast-tracked global effort to develop antibody-based treatments to protect people exposed to the 2019 novel coronavirus disease, COVID-19.

Jeff Balser, MD, PhD, on altering approach to elective care

Here’s the latest information on our coronavirus response. The situation is changing by the hour and we will keep you informed as we determine what’s best for our patients — and for all of us at VUMC.

Suddenly having to work from home can create new challenges

For those who work in an office surrounded by co-workers, working from home can sound like a dream come true — there’s no frustrating commute and you can sit quietly at your own kitchen table or home office, away from the distractions of daily office work life. But if it’s not your choice, it can be a different story.

Ibuprofen and COVID-19: a doctor’s guidance

Last week, France’s health ministry urged people who have been infected by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) to avoid taking over-the- counter nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen and aspirin because they might increase the severity of the infection.

Jeff Balser, MD, PhD, on the importance of social distancing

Download vumc2go, a new workforce app, to connect to COVID-19 updates

A new mobile app connects members of the Vanderbilt University Medical Center community to current COVID-19 news and updates with just a few taps of the finger.